DMSO and colchicine therapy in amyloid disease.
Authors:
- M.A ScheinbergMSM.A Scheinberg
- J.C PernambucoJPJ.C Pernambuco
- M.D BensonMBM.D Benson
Open Access
- 1 June 1984
- journal article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 43 (3) , 421-423
Abstract
There is no specific therapy for primary amyloidosis, and acquired generalised amyloidosis can be treated only if the underlying disease is eliminated. In this study we have investigated the role of colchicine therapy in primary amyloidosis, and dimethylsulphoxide (DMSO) in leprosy associated secondary amyloidosis. No effect on creatinine clearance or 24 h proteinuria could be observed in the patients with primary amyloidosis. In the DMSO group renal function was considerably improved in 3 patients with moderate renal failure but not in those with severe renal impairment (creatinine clearance less than 10 ml/min). Serum SAA determinations were not particularly informative. These findings point to a beneficial effect of DMSO in human secondary amyloidosis when given at an early stage of renal involvement.Keywords
This publication has 9 references indexed in Scilit:
- Prolonged dimethylsulphoxide treatment in 13 patients with systemic amyloidosis.Annals of the Rheumatic Diseases, 1982
- Serum amyloid protein levels in south american children with rheumatoid arthritis: a co-operative study.Annals of the Rheumatic Diseases, 1980
- Humoral and Cellular Aspects of Amyloid Disease: Present Status11980
- SERUM AMYLOID PROTEIN-SAA, C-REACTIVE PROTEIN AND LYSOZYME IN LEPROSY1979
- NEW CONCEPTS IN PATHOGENESIS OF PRIMARY AND SECONDARY AMYLOID DISEASE1978
- Prolonged Colchicine Treatment in Four Patients with AmyloidosisAnnals of Internal Medicine, 1977
- BLOCKAGE OF AMYLOID INDUCTION BY COLCHICINE IN AN ANIMAL MODELJournal of Experimental Medicine, 1974
- Colchicine inhibition of casein-induced amyloidosis in mice.1974
- Leukocytes as secretory organs of inflammationInflammation Research, 1973